Connect with us

Published

on

Continue Reading

TVs Dr. Oz Invested in Businesses Regulated by Agency Trump Wants Him To Lead

Published

on

By

President-elect Donald Trumps choice to run the sprawling government agency that administers Medicare, Medicaid, and the Affordable Care Act marketplace celebrity doctor Mehmet Oz recently held broad investments in health care, tech, and food companies that would pose significant conflicts of interest. Use Our Content

It can be republished for free.

Ozs holdings, some shared with family, included a stake in UnitedHealth Group worth as much as $600,000, as well as shares of pharmaceutical firms and tech companies with business in the health care sector, such as Amazon. Collectively, Ozs investments total tens of millions of dollars, according to financial disclosures he filed during his failed 2022 run for a Pennsylvania U.S. Senate seat.

Trump said Tuesday he would nominate Oz as administrator of the Centers for Medicare & Medicaid Services. The agencys scope is huge: CMS oversees coverage for more than 160 million Americans, nearly half the population. Medicare alone accounts for approximately $1 trillion in annual spending, with over 67 million enrollees.

UnitedHealth Group is one of the largest health care companies in the nation and arguably the most important business partner of CMS, through which it is the leading provider of commercial health plans available to Medicare beneficiaries.

UnitedHealth also offers managed-care plans under Medicaid, the joint state-federal program for low-income people, and sells plans on government-run marketplaces set up via the Affordable Care Act. Oz also had smaller stakes in CVS Health, which now includes the insurer Aetna, and in the insurer Cigna. Email Sign-Up

Subscribe to KFF Health News' free Weekly Edition. Your Email Address Sign Up

It’s not clear if Oz, a heart surgeon by training, still holds investments in health care companies, or if he would divest his shares or otherwise seek to mitigate conflicts of interest should he be confirmed by the Senate. Reached by phone on Wednesday, he said he was in a Zoom meeting and declined to comment. An assistant did not reply to an email message with detailed questions.

Its obvious that over the years hes cultivated an interest in the pharmaceutical industry and the insurance industry, said Peter Lurie, president of the Center for Science in the Public Interest, a watchdog group. That raises a question of whether he can be trusted to act on behalf of the American people. (The publisher of KFF Health News, David Rousseau, is on the CSPI board.)

Oz used his TikTok page on multiple occasions in November to praise Trump and Robert F. Kennedy Jr., including their efforts to take on the illness-industrial complex, and he slammed so-called experts like the big medical societies for dishing out what he called bad nutritional advice. Ozs positions on health policy have been chameleonic; in 2010, he cut an ad urging Californians to sign up for insurance under President Barack Obamas Affordable Care Act, telling viewers they had a historic opportunity.

Ozs 2022 financial disclosures show that the television star invested a substantial part of his wealth in health care and food firms. Were he confirmed to run CMS, his job would involve interacting with giants of the industry that have contributed to his wealth.

Given the breadth of his investments, it would be difficult for Oz to recuse himself from matters affecting his assets, if he still holds them. He could spend his time in a rocking chair if that happened, Lurie said.

In the past, nominees for government positions with similar potential conflicts of interest have chosen to sell the assets or otherwise divest themselves. For instance, Treasury Secretary Janet Yellen and Attorney General Merrick Garland agreed to divest their holdings in relevant, publicly traded companies when they joined the Biden administration.

Trump, however, declined in his first term to relinquish control of his own companies and other assets while in office, and he isnt expected to do so in his second term. He has not publicly indicated concern about his subordinates financial holdings.

CMS main job is to administer Medicare. About half of new enrollees now choose Medicare Advantage, in which commercial insurers provide their health coverage, instead of the traditional, government-run program, according to an analysis from KFF, a health information nonprofit that includes KFF Health News.

Proponents of Medicare Advantage say the private plans offer more compelling services than the government and better manage the costs of care. Critics note that Medicare Advantage plans have a long history of costing taxpayers more than the traditional program.

UnitedHealth, CVS, and Cigna are all substantial players in the Medicare Advantage market. Its not always a good relationship with the government. The Department of Justice filed a 2017 complaint against UnitedHealth alleging the company used false information to inflate charges to the government. The case is ongoing.

Oz is an enthusiastic proponent of Medicare Advantage. In 2020, he proposed offering Medicare Advantage to all; during his Senate run, he offered a more general pledge to expand those plans. After Trump announced Ozs nomination for CMS, Jeffrey Singer, a senior fellow at the libertarian-leaning Cato Institute, said he was uncertain about Dr. Ozs familiarity with health care financing and economics.

Singer said Ozs Medicare Advantage proposal could require large new taxes perhaps a 20% payroll tax to implement.

Oz has gotten a mixed reception from elsewhere in Washington. Pennsylvania Sen. John Fetterman, the Democrat who defeated Oz in 2022, signaled hed potentially support his appointment to CMS. If Dr. Oz is about protecting and preserving Medicare and Medicaid, Im voting for the dude, he said on the social platform X.

Ozs investments in companies doing business with the federal government dont end with big insurers. He and his family also hold hospital stocks, according to his 2022 disclosure, as well as a stake in Amazon worth as much as nearly $2.4 million. (Candidates for federal office are required to disclose a broad range of values for their holdings, not a specific figure.)

Amazon operates an internet pharmacy, and the company announced in June that its subscription service is available to Medicare enrollees. It also owns a primary care service, One Medical, that accepts Medicare and select Medicare Advantage plans.

Oz was also directly invested in several large pharmaceutical companies and, through investments in venture capital funds, indirectly invested in other biotech and vaccine firms. Big Pharma has been a frequent target of criticism and sometimes conspiracy theories from Trump and his allies. Kennedy, whom Trump has said hell nominate to be Health and Human Services secretary, is a longtime anti-vaccine activist.

During the Biden administration, Congress gave Medicare authority to negotiate with drug companies over their prices. CMS initially selected 10 drugs. Those drugs collectively accounted for $50.5 billion in spending between June 1, 2022, and May 31, 2023, under Medicares Part D prescription drug benefit.

At least four of those 10 medications are manufactured by companies in which Oz held stock, worth as much as about $50,000.

Oz may gain or lose financially from other Trump administration proposals.

For example, as of 2022, Oz held investments worth as much as $6 million in fertility treatment providers. To counter fears that politicians who oppose abortion would ban in vitro fertilization, Trump floated during his campaign making in vitro fertilization treatment free. Its unclear whether the government would pay for the services.

In his TikTok videos from earlier in November, Oz echoed attacks on the food industry by Kennedy and other figures in his Make America Healthy Again movement. They blame processed foods and underregulation of the industry for the poor health of many Americans, concerns shared by many Democrats and more mainstream experts.

But in 2022, Oz owned stakes worthas much as $80,000 in Dominos Pizza, Pepsi, and US Foods, as well as more substantial investments in other parts of the food chain, including cattle; Oz reported investments worth as much as $5.5 million in a farm and livestock, as well as a stake in a dairy-free milk startup. He was also indirectly invested in the restaurant chain Epic Burger.

One of his largest investments was in the Pennsylvania-based convenience store chain Wawa, which sells fast food and all manner of ultra-processed snacks. Oz and his wife reported a stake in the company, beloved by many Pennsylvanians, worth as much as $30 million.

Darius Tahir: DariusT@kff.org, @dariustahir Related Topics Elections Health Industry Insurance Medicare CMS Medicare Advantage Trump Administration Contact Us Submit a Story Tip

Continue Reading

Popular anxiety drug being recalled nationwide for ‘possibly life-threatening’ error

Published

on

By

A popular prescription anxiety drug is being recalled nationwide for a “possibly life-threatening” mistake on the carton.

The Pennsylvania-based drug maker Endo announced this week that it is expanding its recall of clonazepam tablets because some cartons bear the incorrect drug strength and wrong drug code.

The new recall affects 16 lots of Clonazepam Orally Disintegrating Tablets, USP (C-IV), with doses ranging from 0.125 milligrams to 2 milligrams.

The packages feature 10 blister strips that each contain six tablets.

They are due to expire between August 2026 and February 2027.

Clonazepam is a benzodiazepine used to treat panic disorder and certain types of seizures.

Endo warns that consuming a higher dose of clonazepam could increase the risk of sleepiness, confusion, dizziness, diminished reflexes and loss of muscle control or strength.

There’s also the risk of “significant, possibly life-threatening” breathing troubles, especially for those with respiratory disease, those being prescribed the maximum dose and those taking other medications that affect breathing.

Endo reports that as of Monday, it has not received any reports of problems stemming from the recall.

The pharmaceutical company announced its initial recall in July of just one lot of clonazepam.

At the time, Endo blamed an “error at a third-party packager” for the mislabeling.

Some cartons showed the product strength as 0.125 mg and not 0.25 mg.

The blister strips inside the package reflected the correct strength, Endo said.

The recalled cartons also list Par Pharmaceuticalof New York as the distributor.

The company, based in Chestnut Ridge, marketed clonazepam before the product was acquired by Endo.

Subscribe to our weekly Post Care newsletter!

Please provide a valid email address.

By clicking above you agree to the Terms of Use and Privacy Policy.

Never miss a story.

People with questions about the recall should call (855) 589-1869 or email rxrecalls@inmar.com.

Retailers with these products are being directed not to sell them, while consumers shouldn’t take them. Consult a physician if you believe you took an incorrect dose of clonazepam.

Continue Reading

Jeff Bezos, Elon Musk feud over Trump election prediction: ‘100% not true’

Published

on

By

Jeff Bezos is pushing back against Tesla CEO Elon Musk’s claim the Amazon founder predicted President-elect Trump would lose the 2024 presidential election.

“Just learned tonight at Mar-a-Lago that Jeff Bezos was telling everyone that @realDonaldTrump would lose for sure, so they should sell all their Tesla and SpaceX stock,” Musk wrote on his social media platform X in the early hours of Thursday morning. 

“Nope. 100% not true,” Bezos replied.

“Well, then, I stand corrected,” Musk responded, with a laughing emoji.

Trump won both the Electoral College and the popular vote in the election and received heavy backing from Musk, whom the president-elect has tapped to co-lead a new Department of Government Efficiency (DOGE) with Vivek Ramaswamy in his second term.

Musk’s cozy relationship with Trump has given investors further confidence in the success of Musk’s companies, particularly Tesla and SpaceX, which has billions in government contracts. Tesla shares have surged nearly 57% over the past month.

Bezos, who owns The Washington Post, did not endorse either presidential candidate this year and sparked a revolt from staffers and subscribers of the newspaper after he halted the editorial board’s endorsement of Vice President Kamala Harris, establishing a new policy of not issuing endorsements for presidential candidates. 

Following the election, Bezos congratulated Trump on X for “an extraordinary political comeback and decisive victory.”

Musk is the world’s richest person with an estimated net worth of $316.2 billion, according to Forbes. Bezos is third on the outlet’s real-time billionaires list with a fortune of $217.4 billion. However, Bezos has been in the top spot several times over the years, most recently in March when he briefly overtook Musk.

Bezos and Musk are also rivals in the space race, where their respective aerospace companies, Blue Origin and SpaceX, compete in space travel and exploration. Amazon, with the help of Blue Origin, is also planning to launch a satellite broadband service, Project Kuiper, to compete with Musk’s Starlink.

Continue Reading

Trending